COST-EFFECTIVENESS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN BRAZIL

被引：0
|
作者：
Tozato, C. [1 ]
Suzuki, C. [1 ]
机构：
[1] Novartis Biociencias SA, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2436
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS42
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [11] Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
    Shah, Dhvani
    Driessen, Maurice
    Risebrough, Nancy
    Baker, Timothy
    Naya, Ian
    Briggs, Andrew
    Ismaila, Afisi S.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2018, 16
  • [12] BUDGET IMPACT ANALYSIS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN COLOMBIA
    Patino, A.
    Karpf, E.
    Londono, D.
    VALUE IN HEALTH, 2017, 20 (09) : A888 - A888
  • [13] Evaluation Of Cost-Effectiveness Of Glycopyrronium Vs. Tiotropium In The Management Of Chronic Obstructive Pulmonary Disease In Taiwan
    Chan, M. -C.
    Lin, T. -C.
    Yang, Y. Kao
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [14] Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
    Dhvani Shah
    Maurice Driessen
    Nancy Risebrough
    Timothy Baker
    Ian Naya
    Andrew Briggs
    Afisi S. Ismaila
    Cost Effectiveness and Resource Allocation, 16
  • [15] Indacaterol for the treatment of chronic obstructive pulmonary disease
    Matera, Maria Gabriella
    Rogliani, Paola
    Cazzola, Mario
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (01) : 107 - 115
  • [16] COST-EFFECTIVENESS OF INDACATEROL ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AT THE PUBLIC MEXICAN HEALTH CARE SYSTEM
    Reyes-lopez, A.
    Lemus-Carmona, E. A.
    Orozco, E.
    VALUE IN HEALTH, 2012, 15 (04) : A55 - A55
  • [17] Cost-effectiveness of indacaterol/glycopyrronium in comparison with salmeterol/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: a LANTERN population analysis from Singapore
    Tee, Augustine
    Chow, Wai Leng
    Burke, Colin
    Guruprasad, Basavarajaiah
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (07) : 383 - 389
  • [18] Evaluating the cost-effectiveness of tiotropium in the treatment of moderate chronic obstructive pulmonary disease
    Naik, S.
    Kamal, K. M.
    Keys, P.
    Mattei, T.
    VALUE IN HEALTH, 2007, 10 (03) : A178 - A179
  • [19] Cost-effectiveness of erdosteine in the treatment of acute exacerbations of chronic obstructive pulmonary disease
    Haughney, J.
    Grishchenko, M.
    Dakin, H. A.
    Ballabio, M.
    Caputo, G.
    THORAX, 2007, 62 : A47 - A47
  • [20] Ultrasound assessment of diaphragmatic dynamics in patients with chronic obstructive pulmonary disease after treatment with indacaterol/glycopyrronium
    Wanguemert-Perez, A. L.
    Figueira-Goncalves, J. M.
    Ramallo-Farina, Y.
    Guanche-Dorta, S.
    Golpe, R.
    REVISTA CLINICA ESPANOLA, 2023, 223 (04): : 216 - 222
12345